Literature DB >> 26985965

Revision to CDC's Zika Travel Notices: Minimal Likelihood for Mosquito-Borne Zika Virus Transmission at Elevations Above 2,000 Meters.

Martin Cetron1.   

Abstract

Since May 2015, when Zika virus, a flavivirus transmitted primarily by Aedes aegypti mosquitoes, was reported in Brazil, the virus has rapidly spread across the Region of the Americas and the Caribbean. The association between maternal Zika virus infection and adverse fetal and reproductive outcomes, including microcephaly, prompted CDC to issue a Level 2 alert travel notice* for the 37 countries and U.S. territories (at the national and territorial level) that have reported recent Zika virus transmission as of March 11, 2016. In addition to mosquito bite precautions for all travelers, CDC advises that pregnant women postpone travel to affected countries and U.S. territories. Within a nation's borders, ecologic characteristics, which determine the distribution of mosquito vectors, can vary considerably. CDC conducted a spatial analysis, focusing on the probability of occurrence of Ae. aegypti, to support the demarcation for subnational travel alerts. Based on results of this analysis, travel that is limited to elevations higher than 2,000 m (6,562 ft) above sea level is considered to have minimal (approximately 1%) likelihood for mosquito-borne Zika virus transmission, even within countries reporting active transmission. Women who are pregnant should avoid travel to elevations <2,000 m in countries with active Zika virus transmission.

Entities:  

Mesh:

Year:  2016        PMID: 26985965     DOI: 10.15585/mmwr.mm6510e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

Review 1.  Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes.

Authors:  Alice Panchaud; Miloš Stojanov; Anne Ammerdorffer; Manon Vouga; David Baud
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

2.  Update on Zika Virus: Considerations for the Traveling Athlete.

Authors:  Brett G Toresdahl; Irfan M Asif
Journal:  Sports Health       Date:  2016-07-19       Impact factor: 3.843

3.  Elevation as a proxy for mosquito-borne Zika virus transmission in the Americas.

Authors:  Alexander G Watts; Jennifer Miniota; Heather A Joseph; Oliver J Brady; Moritz U G Kraemer; Ardath W Grills; Stephanie Morrison; Douglas H Esposito; Adriano Nicolucci; Matthew German; Maria I Creatore; Bradley Nelson; Michael A Johansson; Gary Brunette; Simon I Hay; Kamran Khan; Marty Cetron
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

Review 4.  Geographic components of SARS-CoV-2 expansion: a hypothesis.

Authors:  Kelsey E Joyce; Samuel R Weaver; Samuel J E Lucas
Journal:  J Appl Physiol (1985)       Date:  2020-07-23

5.  Zika Virus, Elevation, and Transmission Risk.

Authors:  A Townsend Peterson; Jorge Osorio; Huijie Qiao; Luis E Escobar
Journal:  PLoS Curr       Date:  2016-05-09

6.  Bioethical considerations at times of Zika virus.

Authors:  Marco Aurélio Scarpinella Bueno; Henrique Grunspun
Journal:  Einstein (Sao Paulo)       Date:  2016 Apr-Jun

7.  Threats of Zika virus transmission for Asia and its Hindu-Kush Himalayan region.

Authors:  Meghnath Dhimal; Sushma Dahal; Mandira Lamichhane Dhimal; Shiva Raj Mishra; Khem B Karki; Krishna Kumar Aryal; Ubydul Haque; Md Iqbal Kabir; Pradeep Guin; Azeem Mehmood Butt; Harapan Harapan; Qi-Yong Liu; Cordia Chu; Doreen Montag; David Alexander Groneberg; Basu Dev Pandey; Ulrich Kuch; Ruth Müller
Journal:  Infect Dis Poverty       Date:  2018-05-15       Impact factor: 4.520

8.  A systematic review and evaluation of Zika virus forecasting and prediction research during a public health emergency of international concern.

Authors:  Pei-Ying Kobres; Jean-Paul Chretien; Michael A Johansson; Jeffrey J Morgan; Pai-Yei Whung; Harshini Mukundan; Sara Y Del Valle; Brett M Forshey; Talia M Quandelacy; Matthew Biggerstaff; Cecile Viboud; Simon Pollett
Journal:  PLoS Negl Trop Dis       Date:  2019-10-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.